ArticleScientific reports2025
Comparative biosafety and efficacy of Pseudomonas fluorescens PFS and Lactiplantibacillus plantarum ZPZ against Ralstonia solanacearum.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Lactiplantibacillus plantarum as a Biosafe Microbial Bridge in the Gut-Environment Continuum.Probiotics and antimicrobial proteins · 2026Review
- A composite medium enabling co-culture ofMethodsX · 2026Article
- Environmental and nutritional determinants of non-infectious pig diseases in Armenia: An ecology-based multi-regional cross-sectional study.Veterinary world · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In light of increasing environmental variability, the biocontrol of Ralstonia solanacearum, one of the most destructive plant pathogens worldwide, remains a pressing challenge. While Pseudomonas fluorescens strains have demonstrated biocontrol efficacy, concerns remain regarding their ecological safety within the One Health framework. These include the production of antimicrobial compounds contributing to resistance gene dissemination, variable efficacy across environments and strains, and occasional adverse effects on plant immunity. As a potential alternative, Lactiplantibacillus plantarum ZPZ, a lactic acid bacterium with GRAS status and cross-domain probiotic features, was comparatively assessed for its efficacy and biosafety profile against R. solanacearum. In vitro experiments showed that the cell-free supernatant of Lpb. plantarum ZPZ inhibited the growth of R. solanacearum by 72.46 ± 14.42% based on OD
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.